Clofibrate reversal of platelet hypersensitivity in hyperbetalipoproteinemia.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D001161:Arteriosclerosis / Q000150:complications / Q000209:etiology; D001792:Blood Platelets / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism / Q000502:physiology; D002250:Carbon Radioisotopes; D002994:Clofibrate / Q000494:pharmacology* / Q000627:therapeutic use; D003094:Collagen / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy / Q000235:genetics / Q000276:immunology; D006949:Hyperlipidemias / Q000097:blood* / Q000150:complications / Q000188:drug therapy / Q000235:genetics / Q000276:immunology; D008077:Lipoproteins, LDL / Q000097:blood*; D008297:Male; D009711:Nucleotides / Q000378:metabolism; D010974:Platelet Aggregation / Q000187:drug effects; D013927:Thrombosis / Q000209:etiology
D002250:Carbon Radioisotopes; D008077:Lipoproteins, LDL; D009711:Nucleotides; D000244:Adenosine Diphosphate; D003094:Collagen; D002994:Clofibrate; D004837:Epinephrine